. 2014 Sep 12;265(6):449–459. doi: 10.1007/s00406-014-0533-5

Table 2.

The comparison of IL-6 levels between schizophrenia patients and healthy controls with respect to distinct genotypes and alleles’ carriers of the IL6 -174 G/C polymorphism

Study group	IL6 -174G/C genotype			p value^a	IL6 -174G/C allele carriers		p value^b
Study group	CC	GC	GG	p value^a	GC + CC	GG	p value^b
SCH	1.30 (0.59–3.42) (n = 21)	1.50 (0.79–3.14) (n = 38)	1.50 (0.72–2.64) (n = 28)	0.81	1.40 (0.69–3.06) (n = 59)	1.50 (0.72–2.64) (n = 28)	0.93
HC	1.24 (0.90–1.60) (n = 22)	0.98 (0.72–1.51) (n = 39)	1.07 (0.72–1.51) (n = 27)	0.51	1.07 (0.81–1.60) (n = 61)	1.07 (0.72–1.51) (n = 27)	0.24

Median values and interquartile range of IL-6 levels are presented [pg/ml]

n number of patients, SCH schizophrenia patients, HC healthy control subjects

^aKruskal–Wallis test, ^b Mann–Whitney U test